Last reviewed · How we verify
NCT04536818
Outcomes After Laparotomy for Penetrating Abdominal Trauma
trial testing Laparotomy in Penetrating Abdominal Trauma in 196 participants. Completed in 30 September 2019.
30 September 2019
Quick facts
| Lead sponsor | Karolinska Institutet |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 196 |
| Start date | 1 April 2019 |
| Primary completion | 30 September 2019 |
| Estimated completion | 30 September 2019 |
| Sites | 1 location across South Africa |
Drugs / interventions tested
- Laparotomy
Conditions studied
- Penetrating Abdominal Trauma — all drugs for Penetrating Abdominal Trauma →
Sponsor
Karolinska Institutet
Who can join
18 and older, any sex, with Penetrating Abdominal Trauma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to evaluate outcomes of adult patients hospitalised due to penetrating abdominal trauma at a tertiary trauma hospital in South Africa. Our primary objective is to study the association between waiting time to surgery and outcome (mortality, complications, and length of hospital stay) in normotensive patients treated with laparotomy for penetrating abdominal trauma.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04536818
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Laparotomy
Trials testing the same drug.
- NCT07094165 — The Effects of Dexmedetomidine and Remifentanil on Kidney Injury After Muscle Compression Injury in Rats · NA · completed
- NCT04985695 — Influence of Analgesic Technique on Post Operative Rehabilitation After Median Laparotomy · NA · recruiting
- NCT04791735 — Value of the Laparoscopic Approach in the Surgical Management of Resectable Hepatocellular Carcinoma · NA · active not recruiting
- NCT04575935 — Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal · Phase 3 · recruiting
- NCT04258631 — Liposomal Bupivacaine With or Without Hydromorphone for the Improvement of Pain Control After Laparotomy in Patients Wit · Phase 4 · completed
Other recruiting trials for Penetrating Abdominal Trauma
Currently open trials in the same condition.
- NCT05127109 — The PASTDUe Nutrition Ecosystem Project (PASTDUe) · Phase 4 · active not recruiting
- NCT07330349 — Alcohol, Psychoactive Drugs, Analgesics and Evaluation in Penetrating Abdominal Trauma · recruiting
Other Karolinska Institutet trials
Trials by the same sponsor.
- NCT06359262 — Evaluating the Hope@School Prevention Program · NA · not yet recruiting
- NCT07289490 — Bilateral vs Unilateral Inguinal Hernia Repairs With an Asymptomatic Inguinal Hernia in Bilateral Hernias · NA · not yet recruiting
- NCT06894264 — Emotion Processing and Regulation in People With Intellectual Disability · NA · not yet recruiting
- NCT07494266 — Safety of a Healthy Plant-based Diet With Higher Potassium Content, Compared to a Healthy Plant-based Diet With Limited · NA · not yet recruiting
- NCT07442032 — Cardiovascular Phenotypes in Sepsis · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04536818 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Karolinska Institutet
- Last refreshed: 3 September 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04536818.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing